FGF19 and hepatocellular carcinoma: The result of ELISA demonstrated that the median serum FGF19 levels in controls, CLD patients, and primary HCC patients were 78.8 pg/mL, 100.1 pg/mL, and 214.5 pg/mL, respectively (Fig. 1).